Get news updates from AACRMeetingNews.org
Subscribe below to get email updates from AACRMeetingNews.org
-
Session focuses on strategies to reduce toxicities of immune cell therapy
Presenters were (from left) Elizabeth J. Shpall, MD, Bianca D. Santomasso, MD, PhD, and Sattva S. Neelapu, MD.
-
Panel discusses importance of academia-industry collaboration
(Clockwise, from top left) Arie S. Belldegrun, MD, Angela N. Koehler, PhD, Levi A. Garraway, MD, PhD, Kristen M. Hege, MD, and Robert I. Tepper, MD, were panelists.
-
Symposium participants discuss modulating metabolism to boost cancer immune response
(From left) Jonathan Powell, MD, PhD, Susan Kaech, PhD, and Ping-Chih Ho, PhD, took part in the session and related panel discussion.
-
Panelists describe combination approaches to overcome drug resistance
(From left) Nathanael S. Gray, PhD, Kwok-Kin Wong, MD, PhD, and Paul Workman, PhD, spoke during the session.
-
Role of chromatin deregulation, metabolism in cancer explored during symposium
The session and panel discussion featured Mathieu Lupien, PhD, Peter W. Lewis, PhD, and Michael D. Taylor, MD, PhD.
-
Symposium explores clinical implications of clonal hematopoiesis in cancer
The session featured (from left) Siddhartha Jaiswal, MD, PhD, Koichi Takahashi, MD, PhD, and Rafael Bejar, MD, PhD.
-
John D. Carpten, PhD, FAACR, to join the AACR Board of Directors
Carpten has made seminal contributions to the understanding of the role of biology in cancer disparities as well as to the field of precision cancer medicine.